As of 3:59pm ET
| +1.16 / +1.45%|
The 9 analysts offering 12-month price forecasts for China Biologic Products Holdings Inc have a median target of 128.00, with a high estimate of 135.00 and a low estimate of 90.40. The median estimate represents a +57.60% increase from the last price of 81.22.
The current consensus among 9 polled investment analysts is to Buy stock in China Biologic Products Holdings Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.